Fucose utilization enhances the efficacy of Bacteroides thetaiotaomicron treatment on alcohol-associated liver disease in mice through regulating ILC3 function Article

Sriwastva, Mukesh K, Lei, Chao, Noud, Collin et al. (2026). Fucose utilization enhances the efficacy of Bacteroides thetaiotaomicron treatment on alcohol-associated liver disease in mice through regulating ILC3 function . Acta Pharmaceutica Sinica B, 10.1016/j.apsb.2026.09.019

cited authors

  • Sriwastva, Mukesh K; Lei, Chao; Noud, Collin; Xu, Zhishan; Wang, Ting; Song, Xiaotong; Tuohongerbieke, Amanguli; Feng, Jing; Gasparetto, Regina; Zhang, Xiang; Feng, Wenke; Tan, Yi; McClain, Craig J; Deng, Zhongbin

authors

publication date

  • September 1, 2026

published in

keywords

  • 2.1 Biological and endogenous factors
  • 3 Good Health and Well Being
  • 32 Biomedical and Clinical Sciences
  • 3204 Immunology
  • Alcoholism, Alcohol Use and Health
  • Chronic Liver Disease and Cirrhosis
  • Digestive Diseases
  • Hepatitis
  • Inflammatory and immune system
  • Liver Disease
  • Microbiome
  • Nutrition
  • Oral and gastrointestinal
  • Substance Misuse

Digital Object Identifier (DOI)

publisher

  • Elsevier